Senate Aligns With House, Proposes $500M For FDA’s COVID-19 Efforts

By Beth Wang / March 3, 2021 at 7:10 PM
Senate Democrats are falling in line with House-passed pandemic relief funding for FDA and HHS, proposing $500 million for FDA review, development and postmarketing surveillance of COVID-19 medical products; $47.8 billion for HHS’ test-and-trace work; and $6 billion for HHS to secure the vaccine, therapeutics and ancillary medical products supply chains, according to their latest draft of relief legislation floated Wednesday (March 3). The FDA funding proposed by Senate Democrats mirrors that included in the version of the American Rescue...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.